Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.555 USD | +2.20% | +1.20% | +8.59% |
04/04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
29/02 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.59% | 35.25M | |
+26.42% | 681B | |
+20.78% | 556B | |
-5.34% | 361B | |
+17.14% | 325B | |
+4.78% | 285B | |
+13.57% | 235B | |
+3.91% | 199B | |
-11.53% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics : Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q1 Revenue $4.1M, vs. Street Est of $4.77M